Objective of the Study Objective of the Study
To detect the T cell receptor Gamma and Delta gene rearrangements in T-cell Acute lymphoblastic Leukemia patients in South India
To Quantitate the Minimal Residual Disease (MRD) in follow-up samples of ALL using Real-time PCR 
TCR Gene Rearrangements TCR Gene Rearrangements
During
Patients and Methods

Patients Patients
54 T-ALL Patients enrolled for MCP 841treatment protocol included for the study Methodology Methodology 10 ml of PB and 2 ml BM collected from the patients were used for study were used for study 
TCRD TCRD gene rearrangements in T gene rearrangements in T--ALL ALL
TCRD rearranged in 16 of 54 cases (29.6%) Vδ1-Jδ1 rearranged in 9 cases (16.6%) Vδ2-Jδ1 and Vδ3-Jδ1 rearranged in one case each (1.8%) Vδ2-Dδ3 in 5 cases (9.25%) and Dδ2-Dδ3 in 4 cases Vδ2-Dδ3 in 5 cases (9.25%) and Dδ2-Dδ3 in 4 cases (7.4%) Junctional region sequence of TCRD (Vδ1-Jδ1, Vδ2-Jδ1 and Vδ3-Jδ1) ranged from 14 to 42 nucleotides (average 27 nucleotides) 
MRD
Conclusion Conclusion
TCRG rearrangements were detected in 68.5% and TCRD in 29.6% of the patients After Induction therapy, in 3 of the 4 patients lesser than 2 leukemic cells in 10 3 normal cells were present and those patients are in clinical and hematological remission MRD quantitation with more number of samples before and after treatment are required to risk stratify the patients Acknowledgements Acknowledgements • Department of Science and Technology, New Delhi.
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